Apparently a chaperone for some membrane-associated process unique to Kinetoplastids.
Uncharacterized Protein, Uncharacterized
Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 11 |
NetGPI | no | yes: 0, no: 11 |
Term | Name | Level | Count |
---|---|---|---|
GO:0016020 | membrane | 2 | 12 |
GO:0110165 | cellular anatomical entity | 1 | 12 |
GO:0005737 | cytoplasm | 2 | 1 |
Related structures:
AlphaFold database: A4ICK3
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 252 | 256 | PF00656 | 0.680 |
CLV_NRD_NRD_1 | 114 | 116 | PF00675 | 0.522 |
CLV_NRD_NRD_1 | 140 | 142 | PF00675 | 0.399 |
CLV_NRD_NRD_1 | 297 | 299 | PF00675 | 0.428 |
CLV_NRD_NRD_1 | 4 | 6 | PF00675 | 0.560 |
CLV_PCSK_FUR_1 | 55 | 59 | PF00082 | 0.439 |
CLV_PCSK_KEX2_1 | 114 | 116 | PF00082 | 0.587 |
CLV_PCSK_KEX2_1 | 139 | 141 | PF00082 | 0.403 |
CLV_PCSK_KEX2_1 | 4 | 6 | PF00082 | 0.560 |
CLV_PCSK_KEX2_1 | 57 | 59 | PF00082 | 0.405 |
CLV_PCSK_PC1ET2_1 | 57 | 59 | PF00082 | 0.422 |
CLV_PCSK_SKI1_1 | 272 | 276 | PF00082 | 0.397 |
CLV_PCSK_SKI1_1 | 299 | 303 | PF00082 | 0.427 |
CLV_PCSK_SKI1_1 | 30 | 34 | PF00082 | 0.491 |
DOC_CYCLIN_yCln2_LP_2 | 279 | 285 | PF00134 | 0.607 |
DOC_MAPK_gen_1 | 139 | 146 | PF00069 | 0.599 |
DOC_MAPK_MEF2A_6 | 239 | 248 | PF00069 | 0.593 |
DOC_PP1_RVXF_1 | 40 | 46 | PF00149 | 0.573 |
DOC_PP2B_LxvP_1 | 279 | 282 | PF13499 | 0.627 |
DOC_PP4_FxxP_1 | 277 | 280 | PF00568 | 0.623 |
DOC_USP7_MATH_1 | 202 | 206 | PF00917 | 0.484 |
DOC_USP7_MATH_1 | 69 | 73 | PF00917 | 0.741 |
DOC_USP7_MATH_1 | 94 | 98 | PF00917 | 0.526 |
DOC_WW_Pin1_4 | 6 | 11 | PF00397 | 0.721 |
LIG_14-3-3_CanoR_1 | 121 | 128 | PF00244 | 0.758 |
LIG_14-3-3_CanoR_1 | 139 | 147 | PF00244 | 0.603 |
LIG_14-3-3_CanoR_1 | 263 | 269 | PF00244 | 0.636 |
LIG_14-3-3_CanoR_1 | 305 | 312 | PF00244 | 0.686 |
LIG_14-3-3_CterR_2 | 310 | 315 | PF00244 | 0.613 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.602 |
LIG_BRCT_BRCA1_1 | 119 | 123 | PF00533 | 0.703 |
LIG_BRCT_BRCA1_1 | 35 | 39 | PF00533 | 0.660 |
LIG_CtBP_PxDLS_1 | 282 | 286 | PF00389 | 0.526 |
LIG_FHA_1 | 276 | 282 | PF00498 | 0.573 |
LIG_FHA_2 | 211 | 217 | PF00498 | 0.625 |
LIG_FHA_2 | 250 | 256 | PF00498 | 0.644 |
LIG_FHA_2 | 48 | 54 | PF00498 | 0.699 |
LIG_LIR_Apic_2 | 275 | 280 | PF02991 | 0.625 |
LIG_LIR_Gen_1 | 92 | 102 | PF02991 | 0.590 |
LIG_LIR_Nem_3 | 100 | 105 | PF02991 | 0.530 |
LIG_LIR_Nem_3 | 158 | 164 | PF02991 | 0.354 |
LIG_LIR_Nem_3 | 92 | 98 | PF02991 | 0.598 |
LIG_MAD2 | 61 | 69 | PF02301 | 0.579 |
LIG_Pex14_2 | 128 | 132 | PF04695 | 0.693 |
LIG_Pex14_2 | 191 | 195 | PF04695 | 0.437 |
LIG_SH2_CRK | 102 | 106 | PF00017 | 0.628 |
LIG_SH2_CRK | 60 | 64 | PF00017 | 0.561 |
LIG_SH2_NCK_1 | 102 | 106 | PF00017 | 0.582 |
LIG_SH2_STAT5 | 177 | 180 | PF00017 | 0.393 |
LIG_SUMO_SIM_par_1 | 299 | 304 | PF11976 | 0.632 |
LIG_TRAF2_1 | 213 | 216 | PF00917 | 0.645 |
MOD_CK1_1 | 17 | 23 | PF00069 | 0.745 |
MOD_CK1_1 | 266 | 272 | PF00069 | 0.477 |
MOD_CK1_1 | 72 | 78 | PF00069 | 0.689 |
MOD_CK2_1 | 19 | 25 | PF00069 | 0.641 |
MOD_CK2_1 | 210 | 216 | PF00069 | 0.470 |
MOD_CK2_1 | 34 | 40 | PF00069 | 0.507 |
MOD_CK2_1 | 47 | 53 | PF00069 | 0.547 |
MOD_CK2_1 | 94 | 100 | PF00069 | 0.406 |
MOD_Cter_Amidation | 112 | 115 | PF01082 | 0.649 |
MOD_GlcNHglycan | 1 | 4 | PF01048 | 0.706 |
MOD_GlcNHglycan | 123 | 126 | PF01048 | 0.680 |
MOD_GlcNHglycan | 17 | 20 | PF01048 | 0.711 |
MOD_GlcNHglycan | 307 | 310 | PF01048 | 0.583 |
MOD_GlcNHglycan | 70 | 74 | PF01048 | 0.616 |
MOD_GlcNHglycan | 86 | 90 | PF01048 | 0.711 |
MOD_GSK3_1 | 117 | 124 | PF00069 | 0.659 |
MOD_GSK3_1 | 15 | 22 | PF00069 | 0.738 |
MOD_GSK3_1 | 164 | 171 | PF00069 | 0.532 |
MOD_GSK3_1 | 262 | 269 | PF00069 | 0.545 |
MOD_GSK3_1 | 68 | 75 | PF00069 | 0.675 |
MOD_N-GLC_1 | 117 | 122 | PF02516 | 0.728 |
MOD_N-GLC_1 | 168 | 173 | PF02516 | 0.602 |
MOD_N-GLC_1 | 283 | 288 | PF02516 | 0.387 |
MOD_N-GLC_2 | 229 | 231 | PF02516 | 0.367 |
MOD_NEK2_2 | 202 | 207 | PF00069 | 0.526 |
MOD_NEK2_2 | 94 | 99 | PF00069 | 0.428 |
MOD_PIKK_1 | 139 | 145 | PF00454 | 0.610 |
MOD_PIKK_1 | 17 | 23 | PF00454 | 0.693 |
MOD_PKA_1 | 139 | 145 | PF00069 | 0.610 |
MOD_PKA_2 | 139 | 145 | PF00069 | 0.546 |
MOD_PKA_2 | 262 | 268 | PF00069 | 0.575 |
MOD_Plk_1 | 168 | 174 | PF00069 | 0.604 |
MOD_Plk_1 | 283 | 289 | PF00069 | 0.591 |
MOD_Plk_1 | 303 | 309 | PF00069 | 0.439 |
MOD_Plk_2-3 | 210 | 216 | PF00069 | 0.575 |
MOD_Plk_2-3 | 49 | 55 | PF00069 | 0.626 |
MOD_ProDKin_1 | 6 | 12 | PF00069 | 0.671 |
TRG_DiLeu_BaLyEn_6 | 142 | 147 | PF01217 | 0.615 |
TRG_ENDOCYTIC_2 | 102 | 105 | PF00928 | 0.410 |
TRG_ENDOCYTIC_2 | 60 | 63 | PF00928 | 0.453 |
TRG_ER_diArg_1 | 139 | 141 | PF00400 | 0.593 |
TRG_ER_diArg_1 | 4 | 6 | PF00400 | 0.763 |
TRG_Pf-PMV_PEXEL_1 | 145 | 149 | PF00026 | 0.344 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P358 | Leptomonas seymouri | 58% | 85% |
A0A0S4IZF1 | Bodo saltans | 29% | 100% |
A0A1X0P876 | Trypanosomatidae | 43% | 97% |
A0A3R7N2F8 | Trypanosoma rangeli | 40% | 100% |
A0A3S7XAJ1 | Leishmania donovani | 100% | 70% |
A4HNZ0 | Leishmania braziliensis | 74% | 100% |
D0A2V8 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 38% | 94% |
E9ASQ2 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 91% | 100% |
Q4Q1U3 | Leishmania major | 96% | 100% |
V5BUV1 | Trypanosoma cruzi | 40% | 97% |